Leukemia News

Several hematologists will be honored during this year’s ASH Annual Meeting.

Individuals with therapy-refractory cancer who received waivers to participate in a clinical trial for off-label targeted therapies achieved similar clinical benefits as those who took part in the study without an exception.

Jae Park, MD, compared the moment to a baby being born.

In this video, Andrew Hantel, MD, discusses the results of a study he helped present at ASCO Annual Meeting on racial disparities in acute myeloid leukemia trials.

In this video, Andrew Hantel, MD, discusses the results of a study he helped present at ASCO Annual Meeting researching inequities in acute myeloid leukemia treatment in historically marginalized communities.

In this video, Christine McMahon, MD, discusses the ACCESS study into post-transplant graft-versus-host disease, presented at ASCO Annual Meeting.

In this video, Christine McMahon, MD, discusses the results of a randomized trial of a care model for patients with acute myeloid leukemia and myelodysplastic syndrome, presented at ASCO Annual Meeting.

In this video, Christine McMahon, MD, discusses the results of the phase 3 ASC4FIRST study, pertaining to chronic myelogenous leukemia, presented at ASCO Annual Meeting.

In this episode of Meeting Mic, we bring you pearls and perspectives from the 2024 ASCO Annual Meeting with a focus on leukemia, as well as Healio’s top headlines from the meeting.

Adults with chronic lymphocytic leukemia under active surveillance had a significantly longer treatment-free survival period if they took vitamin D supplements, results from a retrospective study published in Blood Advances showed.